Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Seymour, JF"" wg kryterium: Autor


Tytuł :
Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies
Autorzy :
Velikova, G
Thanarajasingam, G
Minasian, LM
Baron, F
Cavalli, F
De Claro, RA
Dueck, AC
El-Galaly, TC
Everest, N
Geissler, J
Gisselbrecht, C
Gribben, J
Horowitz, M
Ivy, SP
Jacobson, CA
Keating, A
Kluetz, PG
Krauss, A
Kwong, YL
Little, RF
Mahon, F-X
Matasar, MJ
Mateos, M-V
McCullough, K
Miller, RS
Mohty, M
Moreau, P
Morton, LM
Nagai, S
Rule, S
Sloan, J
Sonneveld, P
Thompson, CA
Tzogani, K
Van Leeuwen, FE
Villa, D
Wingard, JR
Wintrich, S
Seymour, JF
Habermann, TM
Pokaż więcej
Temat :
Hematology [Human health sciences]
Hématologie [Sciences de la santé humaine]
Źródło :
Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies. Lancet. Haematology, 5, 563-598., United KingdomElsevier. (2018).
Opis pliku :
application/pdf
Tytuł :
Female patients with DLBCL and involvement of the reproductive organs have poor outcomes and markedly increased risk of central nervous system relapse with R-CHOP(-like) therapy
Autorzy :
El-Galaly, Tarec Christoffer
Cheah, CY
Hutchings, M.
Sehn, L
Hansen, JW
Poulsen, Mette Østergaard
Rady, K
Juul Mylam, Karen
Larsen, Thomas Stauffer
Holmberg, S.
Juul, Maja Bech
Bech, Sabrina Cordua
Clausen, M R
Jensen, K.B.
Bøgsted, Martin
Johnsen, H.E.
Seymour, JF
Connors, JM
Brown, Peter de Nully
Villa, D
Pokaż więcej
Źródło :
El-Galaly, T C, Cheah, CY, Hutchings, M, Sehn, L, Hansen, JW, Poulsen, M Ø, Rady, K, Juul Mylam, K, Larsen, T S, Holmberg, S, Juul, M B, Bech, S C, Clausen, M R, Jensen, K B, Bøgsted, M, Johnsen, H E, Seymour, JF, Connors, JM, Brown, P D N & Villa, D 2015, ' Female patients with DLBCL and involvement of the reproductive organs have poor outcomes and markedly increased risk of central nervous system relapse with R-CHOP(-like) therapy ', Hematological Oncology (Print), vol. 33, no. S1, pp. 209-11 . https://doi.org/10.1002/hon.2228
Tytuł :
Female patients with DLBCL and involvement of the reproductive organs have poor outcomes and markedly increased risk of central nervous system relapse with R-CHOP(-like) therapy
Autorzy :
El-Galaly, Tarec Christoffer
Cheah, CY
Hutchings, M.
Sehn, L
Hansen, JW
Poulsen, Mette Østergaard
Rady, K
Juul Mylam, Karen
Larsen, Thomas Stauffer
Holmberg, S.
Juul, Maja Bech
Bech, Sabrina Cordua
Clausen, M R
Jensen, K.B.
Bøgsted, Martin
Johnsen, H.E.
Seymour, JF
Connors, JM
Brown, Peter de Nully
Villa, D
Pokaż więcej
Źródło :
El-Galaly, T C, Cheah, CY, Hutchings, M, Sehn, L, Hansen, JW, Poulsen, M Ø, Rady, K, Juul Mylam, K, Larsen, T S, Holmberg, S, Juul, M B, Bech, S C, Clausen, M R, Jensen, K B, Bøgsted, M, Johnsen, H E, Seymour, JF, Connors, JM, Brown, P D N & Villa, D 2015, ' Female patients with DLBCL and involvement of the reproductive organs have poor outcomes and markedly increased risk of central nervous system relapse with R-CHOP(-like) therapy ', 13th International Conference on Malignant Lymphoma, Lugano, Switzerland, 17/06/2015 - 20/06/2015 .
Tytuł :
The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale
Autorzy :
Gallamini, A
Barrington, Sf
Biggi, A
Chauvie, S
Kostakoglu, L
Gregianin, M
Meignan, M
Mikhaeel, Gn
Loft, A
Zaucha, Jm
Seymour, Jf
Hofman, Ms
Rigacci, L
Pulsoni, A
Coleman, M
Dann, Ej
Trentin, L
Casasnovas, O
Rusconi, C
Brice, P
Bolis, S
Viviani, S
Salvi, F
Luminari, Stefano
Hutchings, M.
Pokaż więcej
Tytuł :
Rituximab maintenance for 2-years in patients with untreated high tumor burden follicular lymphoma after response to immunochemotherapy
Autorzy :
Salles, GA
Seymour, JF
Feugier, P
Offner, F
Lopez-Guillermo, A
Bouabdallah, R
Pedersen, LM
Brice, P
Belada, D
Xerri, L
Pokaż więcej
Źródło :
Salles, GA, Seymour, JF, Feugier, P, Offner, F, Lopez-Guillermo, A, Bouabdallah, R, Pedersen, LM, Brice, P, Belada, D & Xerri, L 2010, ' Rituximab maintenance for 2-years in patients with untreated high tumor burden follicular lymphoma after response to immunochemotherapy ', Journal of Clinical Oncology, vol. 28, no. 15s, pp. abstr. 8004 .
Tytuł :
Rituximab maintenance for 2-years significantly improves the outcome of patients with untreated high tumor burden follicular lymphoma after response to immunochemotherapy: results of the PRIMA study
Autorzy :
Salles, G
Catalano, JV
Feugier, P
Offner, F
Bouabdallah, R
Caballero, D
Brice, P
Pedersen, LM
Haioun, C
Belada, D
Delmer, A
Simpson, D
Tilly, H
Leppa, S
Soubeyran, P
Hagenbeek, A
Casasnovas, O
Tanin, I
Ferme, C
Gomes Da Silva, M
Sebban, C
Pettengell, R
Estell, J
Milone, G
Sonnet, A
Lopez-Guillermo, A
Seymour, JF
Xerri, L
Pokaż więcej
Źródło :
Salles, G, Catalano, JV, Feugier, P, Offner, F, Bouabdallah, R, Caballero, D, Brice, P, Pedersen, LM, Haioun, C, Belada, D, Delmer, A, Simpson, D, Tilly, H, Leppa, S, Soubeyran, P, Hagenbeek, A, Casasnovas, O, Tanin, I, Ferme, C, Gomes Da Silva, M, Sebban, C, Pettengell, R, Estell, J, Milone, G, Sonnet, A, Lopez-Guillermo, A, Seymour, JF & Xerri, L 2010, ' Rituximab maintenance for 2-years significantly improves the outcome of patients with untreated high tumor burden follicular lymphoma after response to immunochemotherapy: results of the PRIMA study ', Journal of Clinical Oncology, vol. 28, no. 15s, pp. abstr. 8004 .
Tytuł :
Updated results of the PRIMA study confirms the benefit of 2-years rituximab maintenance in follicular lymphoma patients responding to immunochemotheraphy
Autorzy :
Salles, GA
Catalano, J
Feugier, P
Offner, FC
Bouabdallah, R
Caballero, D
Brice, P
Pedersen, Lars Møller
Haioun, C
Belada, D
Delmer, A
Simpson, D
Tilly, H
Leppa, S
Soubeyran, P
Hagenbeek, A
Casasnovas, O
Intragumtornchai, T
Fermé, C
Gomes de Silva, M
Sebban, C
Lister, A
Esrell, JA
Milone, G
Sonet, A
Lopez-Guillermo, A
Seymour, JF
Pokaż więcej
Źródło :
Salles, GA, Catalano, J, Feugier, P, Offner, FC, Bouabdallah, R, Caballero, D, Brice, P, Pedersen, L M, Haioun, C, Belada, D, Delmer, A, Simpson, D, Tilly, H, Leppa, S, Soubeyran, P, Hagenbeek, A, Casasnovas, O, Intragumtornchai, T, Fermé, C, Gomes de Silva, M, Sebban, C, Lister, A, Esrell, JA, Milone, G, Sonet, A, Lopez-Guillermo, A & Seymour, JF 2010, ' Updated results of the PRIMA study confirms the benefit of 2-years rituximab maintenance in follicular lymphoma patients responding to immunochemotheraphy ', Blood, vol. 116, pp. 746 .
Tytuł :
Azacitidine prolongs overall survival and reduces infections and hospitalizations in patients with WHO-defined acute myeloid leukaemia compared with conventional care regimens: an update
Autorzy :
Fenaux, P
Mufti, Gj
Hellström-Lindberg, E
Santini, V
Gattermann, N
Sanz, G
List, Af
Gore, Sd
Seymour, Jf
Backstrom, J
Zimmerman, L
Mckenzie, D
Beach, Cl
Silverman, Lb.
Pokaż więcej
Temat :
hemic and lymphatic diseases
Short Communications
stomatognathic diseases
neoplasms
Źródło :
ecancermedicalscience. 2
Tytuł :
Results of a randomized trial of chlorambucil versus fludarabine for patients with untreated waldenstrom macroglobulinemia, marginal zone lymphoma, or lymphoplasmacytic lymphoma.
Autorzy :
Leblond V
Johnson S
Chevret S
Copplestone A
Rule S
Tournilhac O
Seymour JF
Patmore RD
Wright D
Morel P
Dilhuydy MS
Willoughby S
Dartigeas C
Malphettes M
Royer B
Ewings M
Pratt G
Lejeune J
Nguyen-Khac F
Choquet S
Pokaż więcej
Źródło :
Journal of Clinical Oncology; 1/20/2013, Vol. 31 Issue 3, p301-307, 7p
Czasopismo naukowe
Tytuł :
5-year survival in patients with relapsed or refractory chronic lymphocytic leukemia in a randomized, phase III trial of fludarabine plus cyclophosphamide with or without oblimersen.
Autorzy :
O'Brien S
Moore JO
Boyd TE
Larratt LM
Skotnicki AB
Koziner B
Chanan-Khan AA
Seymour JF
Gribben J
Itri LM
Rai KR
O'Brien, Susan
Moore, Joseph O
Boyd, Thomas E
Larratt, Loree M
Skotnicki, Aleksander B
Koziner, Benjamin
Chanan-Khan, Asher A
Seymour, John F
Gribben, John
Pokaż więcej
Źródło :
Journal of Clinical Oncology; 11/1/2009, Vol. 27 Issue 31, p5208-5212, 5p
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies